About Q’Apel Medical
Q’Apel Medical is a company based in Fremont (United States) founded in 2019.. Q’Apel Medical has raised $51.9 million across 2 funding rounds from investors including River Cities Capital, Soleus Capital and Research Corporation Technologies. The company has 100 employees as of December 31, 2021. Q’Apel Medical offers products and services including Walrus, Armadillo, and Zebra. Q’Apel Medical operates in a competitive market with competitors including Huake Precision (Beijing) Medical Technology, Zeta Surgical, ClaroNav, InNeuroCo and Brain Navi Biotechnology, among others.
- Headquarter Fremont, United States
- Employees 100 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Qapel Medical Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$51.9 M (USD)
in 2 rounds
-
Latest Funding Round
$29.9 M (USD), Series D
May 10, 2022
-
Investors
River Cities Capital
& 2 more
-
Employee Count
100
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Q’Apel Medical
Q’Apel Medical offers a comprehensive portfolio of products and services, including Walrus, Armadillo, and Zebra. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers optimal support and navigation for neurovascular procedures.
Provides trackability and on-demand support for complex anatomy.
Delivers smooth pushability and stable performance in stroke care.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Q’Apel Medical
Q’Apel Medical has successfully raised a total of $51.9M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $29.9 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series D — $29.9M
-
First Round
First Round
(11 Feb 2021)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2022 | Amount | Series D - Q’Apel Medical | Valuation |
investors |
|
| Feb, 2021 | Amount | Series C - Q’Apel Medical | Valuation | River Cities Capital , Soleus Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Q’Apel Medical
Q’Apel Medical has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include River Cities Capital, Soleus Capital and Research Corporation Technologies. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Research Corporation Technologies is engaged in licensing biomedical technologies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Q’Apel Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - QApel Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Q’Apel Medical Comparisons
Competitors of Q’Apel Medical
Q’Apel Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Huake Precision (Beijing) Medical Technology, Zeta Surgical, ClaroNav, InNeuroCo and Brain Navi Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurosurgery robots are provided for neurological disorder treatments.
|
|
| domain | founded_year | HQ Location |
AI-based navigation and robotics systems for surgeries are developed.
|
|
| domain | founded_year | HQ Location |
Medical 3D visualization and surgical navigation solutions are developed.
|
|
| domain | founded_year | HQ Location |
Intermediate catheters and super distal access device for neurovascular surgery
|
|
| domain | founded_year | HQ Location |
Neurological surgical navigation robots are manufactured by Brain Navi Biotechnology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Q’Apel Medical
Frequently Asked Questions about Q’Apel Medical
When was Q’Apel Medical founded?
Q’Apel Medical was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Where is Q’Apel Medical located?
Q’Apel Medical is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Is Q’Apel Medical a funded company?
Q’Apel Medical is a funded company, having raised a total of $51.9M across 2 funding rounds to date. The company's 1st funding round was a Series C of $22M, raised on Feb 11, 2021.
How many employees does Q’Apel Medical have?
As of Dec 31, 2021, the latest employee count at Q’Apel Medical is 100.
What does Q’Apel Medical do?
QApel Medical was founded in 2019 in Fremont, United States, within the medical devices sector focused on neurovascular interventions. Catheter systems such as the Walrus balloon-based platform and the Wahoo hybrid-access, dual-mode device are offered to support intravascular catheter insertion, guidance, flow control, and traceability. These tools address neurovascular conditions including clots and stroke, aiding clinical procedures in the United States.
Who are the top competitors of Q’Apel Medical?
Q’Apel Medical's top competitors include Huake Precision (Beijing) Medical Technology, Zeta Surgical and ClaroNav.
What products or services does Q’Apel Medical offer?
Q’Apel Medical offers Walrus, Armadillo, and Zebra.
Who are Q’Apel Medical's investors?
Q’Apel Medical has 3 investors. Key investors include River Cities Capital, Soleus Capital, and Research Corporation Technologies.